Meyka AI API is live for developers.Start building.
Advertisement
Check-Cap Ltd.

Check-Cap Ltd. (CHEK) Stock Overview

Explore Check-Cap Ltd.’s financial performance, market position, analyst ratings, and future outlook.

CHEKNASDAQ
HealthcareMedical - Diagnostics & Research
$1.86
$0.03(1.64%)
U.S. Market opens in 54h 32m
Advertisement

Check-Cap Ltd. (CHEK)

Meyka AI Score

Z

Key Financials

Market Cap10.9M
P/E Ratio-0.43
EPS (TTM)$-4.30
ROE-2.26%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 Months$3.19
1 Year Target$0.00

CHEK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Check-Cap Ltd. (CHEK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 0.00, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.43 and a market capitalization of 10.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
12.05%
Year-to-Date (YTD) Change
10.06%
1-Year Change
129.71%
3-Year Change
1.64%
5-Year Change
-94.62%
All-Time (Max) Change
-99.87%

Contact Information

972 4 830 3401
Check-Cap Building, Isfiya, NaN, 30090

Company Facts

850 Employees
IPO DateMar 4, 2015
CountryIL

Frequently Asked Questions